MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹16 Cr | ₹6.98 Cr | ₹2.25 Cr | ₹2.69 Cr | ₹2.48 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹16 Cr |
| Mar2025 | ₹6.98 Cr |
| Mar2024 | ₹2.25 Cr |
| Mar2023 | ₹2.69 Cr |
| Mar2022 | ₹2.48 Cr |
How is Deferred Tax Assets / Liabilities of MOREPEN LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 Cr | 135.90 | |
| Mar2025 | ₹6.98 Cr | 210.09 | |
| Mar2024 | ₹2.25 Cr | -16.23 | |
| Mar2023 | ₹2.69 Cr | 8.18 | |
| Mar2022 | ₹2.48 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,959.4 Cr | -6.4% | -26.8% | 101.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -6.4% |
-26.8% |
101.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses